![John Sundy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sundy
Direktor/Vorstandsmitglied bei
SANOFI
Profil
Dr. John Sundy is an Independent Director at Sanofi and a Chief Medical Officer at Seismic Therapeutic, Inc. He is on the Board of Directors at Sanofi, Childhood Arthritis & Rheumatology Research Alliance and Neutrolis, Inc. Dr. Sundy was previously employed as a Chief Medical Officer by Pandion Therapeutics, Inc., a Senior Vice President by Gilead Sciences, Inc., an Associate Professor by Duke University, and an Associate Professor by Duke-NUS Graduate Medical School Singapore.
He received his undergraduate degree from Bucknell University, a doctorate degree from Hahnemann University and a doctorate degree from Drexel University College of Medicine.
Aktive Positionen von John Sundy
| Unternehmen | Position | Beginn |
|---|---|---|
| SANOFI | Direktor/Vorstandsmitglied | 30.04.2024 |
Neutrolis, Inc.
 Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Direktor/Vorstandsmitglied | - |
Childhood Arthritis & Rheumatology Research Alliance | Direktor/Vorstandsmitglied | - |
Seismic Therapeutic, Inc.
 Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von John Sundy
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.04.2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2014 |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2014 |
| PANDION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John Sundy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Health Technology |
Seismic Therapeutic, Inc.
Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Technology Services |
Childhood Arthritis & Rheumatology Research Alliance |
